Cases of Periodic Disease (Familial Mediterranean fever) among Dagestan Republic population
https://doi.org/10.30629/0023-2149-2020-98-7-536-542
Abstract
The article represents a brief overwiev of current understanding concerning Periodic Disease (Familial Mediterranean fever). There are some recommendations for diagnostics and modern treatment with the use of Colchicine, as a protection from kidney amyloidosis development. Materials are based on the analysis of our own clinical data.
About the Authors
E. M. Esedov
Dagestan State Medical University
Russian Federation
Russian Federation
Makhachkala, 367000
A. S. Abasova
Dagestan State Medical University
Russian Federation
Russian Federation
Albina S. Abasova — MD. PhD, Assotiate Professor of the Department of Hospital Therapy № 2
Makhachkala, 367000
R. A. Medzhidova
Dagestan State Medical University
Russian Federation
Russian Federation
Makhachkala, 367000
L. A. Biyachueva
Dagestan State Medical University
Russian Federation
Russian Federation
Makhachkala, 367000
References
1. Ben-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat. Rev. Rheumatol. 2011;7(2):105– 112.
2. Onen F. Familial Mediterranean fever. Rheumatol. Int. 2006;26(6):489–946.
3. Janeway T.C., Mosenthal H. Unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of nitrogen metabolism. Trans. Assoc. Am. Physicians. 1908;23:504–518.
4. Siegal S. Benign paroxysmal peritonitis. Ann. Intern. Med. 1945;13:1–22.
5. Mamou H., Cattan R. La maladie periodique. Sem. Hop. Paris 1952;28:1062–1070.
6. Heller H., Sohar E., Sherf L. Familial Mediterranean fever. AMA Arch. Intern. Med. 1958;102(1):50–71.
7. Goldfinger S.E. Colchicine for familial Mediterranean fever. N. Engl. J. Med. 1972;287(25):1302.
8. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807.
9. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 1997;17(1):25–31.
10. Fonnesu C., Cerquaglia C., Giovinale M. et al. Familial Medi terra nean Fever: a review for clinical management. Joint Bone Spine 2009;76(3):227–233.
11. Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin. Exp. Rheumatol. 2004;22(34):31–33.
12. Cobankara V., Fidan G., Turk T., Zencir M., Colakoglu M., Ozen S. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin. Exp. Rheumatol. 2004;22(34):27–30.
13. Kisacik B., Yildirim B., Tasliyurt T. et al. Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol. Int. 2009;29(11):1307–1309.
14. Lidar M., Yaqubov M., Zaks N., Ben-Horin S., Langevitz P., Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J. Rheumatol. 2006;33(6):1089–1092.
15. Cobankara V., Balkarli A. Ailesel Akdeniz Ateşi. Pam. Med. J. 2011;4(2):86–98.
16. Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.
17. Demirturk L., Ozel A.M., Cekem K., Yazgan Y., Gultepe M. Coexistence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks. Dig. Liver Dis. 2005;37(3):153–158.
18. Ozel AM, Demirturk L, Aydogdu A, et al. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Int. J. Clin. Pract. 2008;62(5):754–761.
19. Ben-Chetrit E., Ben-Chetrit A. Familial Mediterranean fever and menstruation. BJOG 2001;108(4):403–407.
20. Toubi E., Gershoni-Baruch R., Kuten A. Cisplatin treatment triggers familial Mediterranean fever attacks. Tumori. 2003;89(1):80–81.
21. Shohat M, Halpern GJ. Familial Mediterranean fever — a review. Genet. Med. 2011;13(6):487–498.
22. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.
23. Soylu A, Kasap B, Turkmen M, Saylam GS, Kavukcu S. Febrile myalgia syndrome in familial Mediterranean fever. J. Clin. Rheumatol. 2006;12(2):93–96.
24. Salugina S.O., Fedorov E.S. Experience of diagnostics, treatment and curation of patients with cryopyrin-associated periodic syndromes in rheumatological practice. Pediatrics. 2018;97(3):103–109. (in Russian).
25. Rameev V.V., Bogdanova M.V., Fedorov E.S., Salugina S.O., Simonyan A.Kh., Moiseev S.V. Kozlovskaya L.V., Mukhin N.A. Modern approaches to the treatment of colchicineresistant periodic disease. Clinical pharmacology and therapy. 2017;26(3):59–68. (in Russian)
Review
For citations:
Esedov E.M., Abasova A.S., Medzhidova R.A., Biyachueva L.A. Cases of Periodic Disease (Familial Mediterranean fever) among Dagestan Republic population. Clinical Medicine (Russian Journal). 2020;96(7):536-542. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-7-536-542
Views:
993
Email this article 